Proposed federal legislation, called the Rural 340B Access Act, would allow rural emergency hospitals (REHs) to use the 340B federal drug discount program. Currently, hospitals with the REH designation aren't eligible for the 340B program.
Community Hospital Corporation’s Post
More Relevant Posts
-
Are you a Medicare beneficiary who is struggling to lose weight? You could be one of the 3.6 million enrollees who may now qualify for coverage of the anti-obesity drug, Wegovy. Check out details about eligibility, cost, and how this could affect premiums: https://bit.ly/3UcLkPm #Medicare #weightloss
3.6 million Medicare enrollees may now be eligible for Wegovy coverage | CNN
cnn.com
To view or add a comment, sign in
-
| Financial Planner, Ball Financial Services | ChFC | Wealth Management | CLTC | Long Term Care | Estate Planning | Retirement Income Planning |
Are you a Medicare beneficiary who is struggling to lose weight? You could be one of the 3.6 million enrollees who may now qualify for coverage of the anti-obesity drug, Wegovy. Check out details about eligibility, cost, and how this could affect premiums: https://bit.ly/3UcLkPm #Medicare #weightloss
3.6 million Medicare enrollees may now be eligible for Wegovy coverage | CNN
cnn.com
To view or add a comment, sign in
-
Are you a Medicare beneficiary who is struggling to lose weight? You could be one of the 3.6 million enrollees who may now qualify for coverage of the anti-obesity drug, Wegovy. Check out details about eligibility, cost, and how this could affect premiums: https://bit.ly/3UcLkPm #Medicare #weightloss
3.6 million Medicare enrollees may now be eligible for Wegovy coverage | CNN
cnn.com
To view or add a comment, sign in
-
Congress is Knocking on 340B's Door, Saying "Show Me the Money" 💵 Many members of society are adversely affected by inequalities stemming from diverse circumstances and socio-economic realities. Disparities in public health result from those inequalities. Policy is one avenue for improving the health of those in need. One policy response by Congress was the creation of the 340B Drug Pricing Program as part of the bipartisan Veterans Healthcare Act of 1992. The 340B program allows qualifying safety-net providers and qualifying hospitals, otherwise known as covered entities, to purchase prescription drugs at significantly discounted prices from manufacturers and re-invest those dollars in expanding access to care and treatment. A growing chorus is concerned that the legislative intent of the program is being obfuscated by large hospital systems and mega service providers. Read more: https://lnkd.in/gNSpZkMP
Congress is Knocking on 340B's Door, Saying "Show Me the Money"
adapadvocacyassociation.blogspot.com
To view or add a comment, sign in
-
🏥 𝐂𝐌𝐒 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐞𝐬 '𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐒𝐭𝐚𝐛𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧' 𝐭𝐨 𝐁𝐚𝐥𝐚𝐧𝐜𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐨𝐬𝐭𝐬! 🌟 𝐈𝐧 𝐉𝐮𝐥𝐲 𝟐𝟎𝟐𝟒, The Centers for Medicare & Medicaid Services is creating a #voluntary demonstration program to support changes to Medicare Part D under the Inflation Reduction Act. The agency also finalized bid information for contract year 2025, with a base beneficiary premium #increase of $2.08 for people with Part D. According to the new program, all participating stand-alone prescription #drug plans will see a $15 base beneficiary premium #reduction; in certain situations, this will result in a $0. Part D #premium. The entire Part D premium for a plan will be subject to an annual increase cap of $35. In order to "provide for greater government risk sharing for potential plan losses," risk corridors can finally be modified. It is designed to cap the IRA's yearly premium increases between contract year 2024 and 2029. A press release states that CMS is creating the Part D Premium Stabilization Demonstration in order to "improve premium stability for participating stand-alone prescription drug plans" since beneficiaries may experience plan price volatility as a result of Part D and prescription drug plans. 𝘽𝙧𝙤𝙬𝙨𝙚 𝙖𝙩 𝙤𝙪𝙧 𝙍𝙚𝙡𝙖𝙩𝙚𝙙 𝙍𝙚𝙥𝙤𝙧𝙩 👉: https://bit.ly/3WtKZJ9 #PremiumStabilization #HealthcareReform #AffordableCare #InsuranceStability #HealthCoverage #HealthcareNews #PolicyUpdate #CMSInitiative #prophecymarketinsights
To view or add a comment, sign in
-
Pretty big news in the #GLP1 and #obesity care space today, with #CMS now saying they will cover agents (with CV outcomes data and approval) to reduce the risk of major cardiovascular adverse events (#MACE) in patients with established #cardiovascular disease. The big surprise (to me, at least) is that CMS made this change by regulation instead of waiting for a change in law. While this decision is within CMS's statutorily defined abilities, that they took the step is encouraging. Particularly because the government will negotiate prices by active ingredient (e.g., Ozempic and Wegovy), the immediate-term opportunity to open access to Medicare-covered patients incentivizes CV outcomes trials for any agent that might get both a weight management label along with any other indication that would be covered. Since this change impacts Part D plans, an open question is how these plans will verify the drug is used for MACE reduction versus "just" weight reduction. In this area, it will be instructive to follow all three of the policy, process, and PA form. https://lnkd.in/gZV_keKn
Exclusive | Medicare Opens Door for Covering Obesity Drugs
wsj.com
To view or add a comment, sign in
-
Congress tries to help rural communities, then greedy hospitals and pharmacies undermine rural programs. Perhaps the complexities of our healthcare system creates smokescreens for abusers? How does the 340B Drug Pricing Program coordinate with the Inflation Reduction Act to achieve lower prices for seniors? Has this program coordinated with Medicare Part D in the past? #medicarepartd #seniors #drugdiscount #340bdrugpricingprogram #drugsavings https://lnkd.in/g9uE-eh2
Federal Safety Net Drug Pricing Program Leaves Rural Patients and Seniors Behind
realclearhealth.com
To view or add a comment, sign in
-
As president of the Lower Out-of-Pockets NOW Coalition, I can’t thank President Biden enough for endorsing the coalition's newest proposal to put a cap on drug costs. Read more about the proposal here: https://lnkd.in/eRxpWBgF #betterhealthcare #democracynow #healthcaresystem #betterhealth #healthinsurance #insuranceindustry #politics #congress #healthcarenow #improvehealthcare #drugcosts #medicalcosts #hospitals #healthsystems #healthylifestyle #healthpolicy
President Biden proposes $2,000-a-year limit on prescription drugs
wendellpotter.substack.com
To view or add a comment, sign in
-
#CMS released the Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Final Rule this week. Although some of the most talked-about changes originally proposed last year were not included, notable updates to the #Medicaid Drug Rebate Program did make it through. In today's #healthcare alert, Senior Policy Advisor Miranda Franco breaks down what you need to know. https://bit.ly/3XWJOUD #healthcareindustry #healthcarepolicy
To view or add a comment, sign in
-
📈 10M+ Views | 🚀 Turning Data into Actionable Insights | 🤖 AI, ML & Analytics Expert | 🎥 Content Creator & YouTuber | 💻 Power Apps Innovator | 🖼️ NFTs Advocate | 💡 Tech & Innovation Visionary | 🔔 Follow for More
Summary: Over a million Medicare beneficiaries could save thousands of dollars on out-of-pocket drug costs in 2025 under Biden's Inflation Reduction Act, which caps drug costs at $2,000. This relief is expected to benefit older adults with chronic health conditions, and the act aims to keep Medicare plans affordable over time. Takeaway: The Inflation Reduction Act is set to provide significant relief for Medicare beneficiaries facing high out-of-pocket drug costs, particularly for those with chronic health conditions. This move aligns with the widespread support for lowering prescription drug costs and protecting Medicare funding among voters. Hashtags: #Medicare #PrescriptionDrugs #InflationReductionAct #HealthcareAffordability #MedicareBeneficiaries #BidenAdministration
Summary: Over a million Medicare beneficiaries could save thousands of dollars on out-of-pocket drug costs in 2025 under Biden's Inflation Reduction Act, which caps drug costs at $2,000. This relief is expected to benefit older adults with chronic health conditions, and the act aims to keep Medicare plans affordable over time. Takeaway: The Inflation Reduction Act is set to provide significa...
businessinsider.com
To view or add a comment, sign in
7,290 followers
Experienced Healthcare Executive
3moChristopher Murray San Augustine 🤔🤔